Analysts' Actions: BRCM CTXS EA LNKD VCLK

NEW YORK ( TheStreet) -- CHANGE IN RATINGS

Applied Industrial ( AIT) was downgraded at Wunderlich to hold from buy. Valuation call, based on a $56 price target, Wunderlich said.

Broadcom ( BRCM) was downgraded at UBS to neutral from buy. Connectivity headline risk, said UBS. Price target goes to $30.

BRE Properties ( BRE) was downgraded at UBS to neutral from buy. The sale to Land & Buildings is unlikely, said UBS. Price target goes to $55.

Citrix Systems ( CTXS) was upgraded at Credit Suisse to outperform from neutral. XenMobile and the partnership with Cisco are expected to reaccelerate growth, Credit Suisse said.

Cubic ( CUB) was upgraded at Benchmark to buy from hold. $60 price target. The defense backlog is improving in a challenging environment, Benchmark said.

Electronic Arts ( EA) was initiated with a buy rating and $30.83 price target at Benchmark. Battlefield 4 can drive near-term growth, Benchmark said.

Garmin ( GRMN) was upgraded to buy at TheStreet Ratings.

HSN ( HSNI) was upgraded at Wunderlich to buy from hold. $75 price target. Company has competitive advantages, especially in mobile, Wunderlich said.

ITT ( ITT) was upgraded at FBR Capital Markets to market perform from underperform. $32 price target. The outlook is improving in Europe, and investors are favoring industrial names, FBR Capital Markets said.

Ligand Pharmaceuticals ( LGND) was downgraded at Cantor Fitzgerald to sell from hold. The loss of two late-stage clinical programs outweighs second-quarter 2013 performance. Price target is $37.

Linear Technology ( LLTC) was downgraded at UBS to neutral from buy. Valuation and slowing wireless growth, said UBS. Price target is $40.

LinkedIn ( LNKD) was upgraded at Cantor Fitzgerald to buy from hold. $250 price target. Long-term outlook continues to improve, Cantor Fitzgerald said.

Mosaic ( MOS) was downgraded at UBS to neutral from buy. Reflects breakdown of a potash cartel, said UBS. Price target goes to $40.

Mylan ( MYL) was upgraded at Morgan Stanley to overweight from equal-weight. Price target is $41. Management has outlined key future growth opportunities, and the current valuation is attractive, Morgan Stanley said.

Mylan was downgraded at Needham to buy from strong buy. Valuation call, based on a $40 price target, Needham said.

If you liked this article you might like

Cramer: Dominoes Are in Play Today

Fedex, Apple Are on a Roll Explains Jim Cramer

Cramer: These Stocks Are Playing Catch-Up

Toshiba Reportedly Favoring Broadcom in Flash Business Sale

Bank Earnings Are at a Critical Turning Point: Cramer's 'Mad Money' Recap (Wednesday 4/12/17)